Drug Topics

JULY 6, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Vaccines 343

Vaccines Immunization Insurance Communication 343

The Guardian - Pharmaceutical Industry

JULY 6, 2025

Testing is difficult for drugs for rare diseases, and new rules may make it harder for sufferers to obtain life-saving drugs US drug regulators have increasingly signaled a focus on faster approvals and rare diseases, but patients with ultra-rare ailments fear they are falling through the cracks, especially given challenges to conducting clinical trials.

FDA 85

FDA 85

Pharmacy Times

JULY 6, 2025

GLP-1 medications like semaglutide face scrutiny over compounded versions, raising concerns about patient safety and counterfeit products in diabetes treatment.

Compounding 65

Compounding 65

Med Ed 101

JULY 6, 2025

If you’re a pharmacist or pharmacy student looking to test your knowledge of nonsteroidal anti-inflammatory drugs (NSAIDs), we’ve got the perfect brain-teasing activity for you. Introducing our NSAID Crossword Puzzle—a fun, interactive way to review key drug facts while sharpening your clinical memory. You’ll find the answers to our NSAID Crossword Puzzle at the end […] The post Can You Pass?

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

STAT

JULY 6, 2025

As the National Institutes of Health recently paused its campaign to terminate billions of dollars in grants , its parent agency was starting to lay out a more cautious and legally rigorous strategy for canceling research deemed out of step with Trump administration priorities, an internal memo shows.  Guidance from the Office of the General Counsel at the Department of Health and Human Services, obtained by STAT, outlines a new legal advisory process and advice to staffers on the justifica

121

121